NEPHROS INC
NEPHNASDAQTrading Snapshot
- Day Range
- $3.86 β $3.91
- 52-Week Range
- $2.66 β $6.42
- Volume
- $4.92B
- Avg Volume
- $5.71B
- Shares Outstanding
- 10.9M
- Next Earnings
- Nov 21, 2026
Fundamentals Snapshot
- Annual Revenue
- $19M
- Last Q Revenue
- $6M
- P/E Ratio
- 25.1
- P/S Ratio
- 2.1x
- EPS (TTM)
- $0.16
- Dividend Yield
- β
- Dilution (1yr)
- +3.9%
Why Investors Own NEPH
- βHigh-growth profile β revenue up -6.3% YoY with expanding US Equity exposure.
- βHealthy economics β 35% gross margin and 19% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
NEPHROS INC
NEPHAbout NEPHROS INC
Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, actionable data regarding waterborne pathogens. Furthermore, under its Renal Products segment, the company provides medical devices designed for individuals suffering from renal disease, notably including a second-generation hemodiafiltration system tailored for patients with end-stage renal disease. Additionally, Nephros markets a range of water filters under the Nephros and AETHER brands. These filters are engineered not only to enhance water taste and eliminate odors but also to significantly reduce biofilm, bacteria, and scale accumulation in downstream equipment, serving the food service, hospitality, convenience store, and healthcare industries. Established in 1997, Nephros, Inc. maintains its corporate headquarters in South Orange, New Jersey.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
NEPHROS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift NEPH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
NEPHROS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.